POMDOCTOR LIMITED American Depositary Shares (POM) Stock Analysis — PE Ratio, PS Ratio, Intrinsic Value & 2030 Price Target
POMDOCTOR LIMITED American Depositary Shares stock (POM) is currently trading at $0.28. POMDOCTOR LIMITED American Depositary Shares PS ratio (Price-to-Sales) is 0.11. WallStSmart rates POM as Sell.
- POM PE ratio analysis and historical PE chart
- POM PS ratio (Price-to-Sales) history and trend
- POM intrinsic value — DCF, Graham Number, EPV models
- POM stock price prediction 2025 2026 2027 2028 2029 2030
- POM fair value vs current price
- POM insider transactions and insider buying
- Is POM undervalued or overvalued?
- POMDOCTOR LIMITED American Depositary Shares financial analysis — revenue, earnings, cash flow
- POM Piotroski F-Score and Altman Z-Score
- POM analyst price target and Smart Rating
POMDOCTOR LIMITED American Depositary Shares
📊 No data available
Try selecting a different time range
Smart Analysis
POMDOCTOR LIMITED American Depositary Shares (POM) · 6 metrics scored
Smart Score
Category Performance
WallStSmart pulls financial metrics like revenue growth, profit margins, and valuation ratios and scores each one from 0 to 10 based on how strong or weak it is. Those 10 scores are grouped into 4 categories: Growth, Profitability, Valuation, and Quality — which form the 4 axes of the spider chart you see. The categories are then combined into a final score out of 100, but not equally. Growth and Profitability together count for 60% of the total, because a fast-growing profitable business matters more than just a cheap one. That final number maps to a rating (Strong Buy, Buy, Hold, Avoid) and a letter grade, giving you one clear Stock Rating.
Investment Thesis
Strong fundamentals in price/sales. Concerns around market cap and operating margin. Significant fundamental concerns warrant caution or avoidance.
POMDOCTOR LIMITED American Depositary Shares (POM) Key Strengths (1)
Paying less than $1 for every $1 of annual revenue
Supporting Valuation Data
POMDOCTOR LIMITED American Depositary Shares (POM) Areas to Watch (5)
Losing money on operations
Company is losing money with a negative profit margin
Very low institutional interest at 0.73%
Micro-cap company with very limited liquidity and high volatility
Solid revenue growth at 16.20% per year
POMDOCTOR LIMITED American Depositary Shares (POM) Detailed Analysis Report
Overall Assessment
This company scores 22/100 in our Smart Analysis, earning a F grade. Out of 6 metrics analyzed, 1 register as strengths (avg 10.0/10) while 5 fall into concern territory (avg 2.2/10). The category breakdown reveals uneven performance, with some areas requiring attention.
The Bull Case
The strongest argument centers on Price/Sales. Valuation metrics including Price/Sales (0.11) suggest the stock is attractively priced.
The Bear Case
The primary concerns are Operating Margin, Profit Margin, Institutional Own.. Growth concerns include Revenue Growth at 16.20%, which may limit upside. Profitability pressure is visible in Operating Margin at -6.55%, Profit Margin at -40.60%.
Key Dynamics to Monitor
Three factors to monitor going forward. First, whether Operating Margin improves, as this is the primary drag on the overall score. Second, margin trajectory, with Operating Margin at -6.55% needing improvement to support the investment thesis. Third, growth sustainability, with Revenue Growth at 16.20% needing to reaccelerate.
Risk Considerations
Based on the metric profile, this is a higher risk investment. There are more areas of concern than strength, warranting a more conservative position size. Investors should size positions according to their risk tolerance and maintain diversification.
Bottom Line
Fundamental challenges outweigh strengths at current levels. Operating Margin and Profit Margin are the primary drags. Consider waiting for meaningful improvement before committing capital.
Disclaimer: Smart Analysis is a scoring system developed by WallStSmart Team. Scores update daily using multi-model valuation framework. Always conduct your own research and consult with financial advisors before making investment decisions.
POM Price-to-Sales(PS) Ratio Chart
Historical valuation based on market cap ÷ trailing 12-month revenue
POM's Price-to-Sales ratio of 0.11x trades at a deep discount to its historical average of 0.33x (42th percentile). The current valuation is 94% below its historical high of 1.69x set in Oct 2025, and 56% above its historical low of 0.07x in Jan 2026. Over the past 12 months, the PS ratio has compressed from ~1.7x as trailing revenue scaled faster than the stock price.
WallStSmart Analysis Synopsis
Data-driven financial summary for POMDOCTOR LIMITED American Depositary Shares (POM) · HEALTHCARE › PHARMACEUTICAL RETAILERS
The Big Picture
POMDOCTOR LIMITED American Depositary Shares is a strong growth company balancing expansion with improving profitability. Revenue reached 367M with 16% growth year-over-year. The company is currently unprofitable, posting a -40.6% profit margin.
Key Findings
Debt-to-equity ratio of -0.19 indicates a conservative balance sheet with 8M in cash.
The company is unprofitable with a -40.6% profit margin. The path to breakeven will be the key catalyst.
Free cash flow is -16M, meaning the company is burning cash. This may be acceptable for high-growth companies investing heavily.
What to Watch Next
Debt management: total debt of 441M is significantly higher than cash (8M). Monitor refinancing risk.
Sector dynamics: monitor PHARMACEUTICAL RETAILERS industry trends, competitive moves, and regulatory changes that could impact POMDOCTOR LIMITED American Depositary Shares.
Bottom Line
POMDOCTOR LIMITED American Depositary Shares offers an attractive blend of growth (16% revenue expansion) and improving fundamentals. The company is transitioning from pure growth to profitable growth, a critical inflection point. Watch for sustained margin expansion as the key signal.
This synopsis is generated from publicly available financial data. It is not financial advice. Always conduct your own research and consult a qualified financial advisor before making investment decisions.
Insider Transactions
Loading insider activity...
About POMDOCTOR LIMITED American Depositary Shares(POM)
NASDAQ
HEALTHCARE
PHARMACEUTICAL RETAILERS
USA
Pomdoctor Limited, offers an online B2C portal to sell pharmaceutical products. The company is headquartered in Guangzhou, China.